These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7731548)

  • 1. Effect of locally infused 2-chloroadenosine, an A1 receptor agonist, on spontaneous and evoked dopamine release in rat neostriatum.
    Ballarin M; Reiriz J; Ambrosio S; Mahy N
    Neurosci Lett; 1995 Feb; 185(1):29-32. PubMed ID: 7731548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release.
    Jin S; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):48-56. PubMed ID: 9007842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release.
    Zetterström T; Fillenz M
    Eur J Pharmacol; 1990 May; 180(1):137-43. PubMed ID: 2364998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S; Johansson B; Fredholm BB
    J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
    Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
    Pharmacol Rep; 2008; 60(3):319-30. PubMed ID: 18622056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.
    Umeda Y; Sumi T
    Eur J Pharmacol; 1990 Nov; 191(2):149-55. PubMed ID: 2086236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
    Bowyer JF; Masserano JM; Weiner N
    J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum.
    Golembiowska K; Zylewska A
    Brain Res; 1998 Sep; 806(2):202-9. PubMed ID: 9739141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival of intrastriatal dopaminergic grafts: modulation of acetylcholine release by graft-derived dopamine.
    Jackisch R; Duschek M; Neufang B; Rensing H; Hertting G; Herman JP
    J Neurochem; 1991 Jul; 57(1):267-76. PubMed ID: 2051168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that adenosine A2 and dopamine autoreceptors antagonistically regulate tyrosine hydroxylase activity in rat striatal synaptosomes.
    Onali P; Olianas MC; Bunse B
    Brain Res; 1988 Jul; 456(2):302-9. PubMed ID: 2905190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceruletide, a cholecystokinin-related peptide, attenuates haloperidol-induced increase in dopamine release from the rat striatum: an in vivo microdialysis study.
    Kihara T; Ikeda M; Matsushita A
    Brain Res; 1990 Jun; 519(1-2):44-9. PubMed ID: 2397417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
    Gołembiowska K; Zylewska A
    Pol J Pharmacol; 1997; 49(5):317-22. PubMed ID: 9566030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats.
    Miller DW; Abercrombie ED
    Brain Res Bull; 1996; 40(1):57-62. PubMed ID: 8722754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.
    Porras G; De Deurwaerdère P; Moison D; Spampinato U
    Eur J Neurosci; 2003 Feb; 17(4):771-81. PubMed ID: 12603267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis.
    Okada M; Kiryu K; Kawata Y; Mizuno K; Wada K; Tasaki H; Kaneko S
    Eur J Pharmacol; 1997 Feb; 321(2):181-8. PubMed ID: 9063686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose deprivation increases basal and electrically evoked transmitter release from rat striatal slices. Role of NMDA and adenosine A1 receptors.
    Jin S; Fredholm BB
    Eur J Pharmacol; 1997 Dec; 340(2-3):169-75. PubMed ID: 9537811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.